Aspirin did not provide any clinical benefits in a cohort of patients with colorectal cancer who had no history of cardiovascular disease or stroke.

Researchers, federal employees, and members of the public have voiced concerns about restrictions recently placed on federal health agencies.

Single-agent adjuvant chemotherapy did not improve overall survival when compared to no adjuvant chemotherapy.

The FDA has warned Sanofi about significant deviations from Current Good Manufacturing Practice regulations for active pharmaceutical ingredients.